Coya Therapeutics, Inc. (COYA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD

Add to watchlist

8.40

+0.15

(+1.82%)

At close: 04:00PM EDT

8.37

-0.03

(-0.36%)

After hours:

05:17PM EDT

Loading interactive chart...

Simply Wall St.
Coya Therapeutics, Inc.'s (NASDAQ:COYA) largest shareholders are retail investors with 60% ownership, insiders own 16%
Key Insights The considerable ownership by retail investors in Coya Therapeutics indicates that they collectively have...
GuruFocus.com
Coya Therapeutics Reports First Quarter 2024 Financial Results
Performance Misses Analyst Estimates Amidst Expanding Clinical Pipeline
Business Wire
Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results
HOUSTON, May 09, 2024--Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a corporate update and announces its financial results for the quarter ended March 31, 2024.